The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Positive Trading Update

7 Sep 2010 07:00

RNS Number : 2445S
Intercede Group PLC
07 September 2010
 



7 September 2010

Intercede Group plc

("Intercede")

 

Positive Trading Update

 

Intercede announces strong levels of business throughout the summer period.

The Healthcare sector has made a significant contribution to revenue and in July orders from an existing UK customer generated more than £800,000 in cash receipts. 

US government customers have continued to buy additional software licenses and a further US Federal Agency has purchased the Intercede MyID system. This brings the total number of Agencies using Intercede MyID for HSPD-12/PIV compliance to 13. Lockheed Martin and FAA continue to buy materially significant quantities of professional service time from Intercede in support of their large enterprise-wide identity programs.

Internationally, Intercede has added the Australian government and a South African bank to its customer list. Additional revenues are accruing for the next phase of the Kuwait national ID program and an existing customer that has purchased Intercede MyID to power a Switzerland-wide electronic identity service.

Intercede's sales activities continue to increase the pipeline of future business. A number of contract awards are also pending imminent closure, and the company is on target to meet full year expectations. Intercede remains in a strong cash position at the end of August.

Richard Parris, Chairman and Chief Executive of Intercede, said:

"Our level of business activity is at an all time high driven by repeat orders against existing contracts, new orders from new customers and a growing pipeline of high value prospects. Although, as expected, we have seen a reduction in UK Government orders compared to the same period last year, this is being compensated for by international orders, particularly from the US."

About Intercede

Intercede is the producer of the MyID Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organisations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include more than 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit http://www.intercede.com

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. + 44 (0)20 7600 1658

Clive Carver

Sarah Wharry

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Francesca Tuckett

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKADDFBKDKCK
Date   Source Headline
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement
20th Dec 200511:29 amRNSDirector/PDMR Shareholding
15th Dec 20057:00 amRNSInterim Results
12th Dec 200512:28 pmRNSRe New OEM Agreement
9th Dec 200512:47 pmRNSHolding(s) in Company
30th Nov 200510:42 amRNSFurther re OEM Agreement
21st Nov 20051:44 pmRNSFurther re Global OEM Licence
12th Sep 20057:00 amRNSRe: Global OEM Licence
13th Jun 20054:12 pmRNSHolding(s) in Company-Amend
25th May 200512:04 pmRNSHolding(s) in Company
24th May 20057:00 amRNSFinal Results
31st Mar 20057:00 amRNSTrading Statement
24th Feb 200512:48 pmRNSRe Contract
21st Jan 20059:11 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.